AI assistant
Sending…
LifeMD, Inc. — Director's Dealing 2020
Sep 24, 2020
33298_dirs_2020-09-24_18cd64f5-32d2-4177-9a9d-2c93ed679b2f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONVERSION LABS, INC. (CVLB)
CIK: 0000948320
Period of Report: 2020-09-23
Reporting Person: Galluppi Stefan (Director, Chief Operating Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-09-23 | Common Stock, par value $0.01 | S | 401000 | $1.00 | Disposed | 749000 | Indirect |
Footnotes
F1: Mr. Galluppi has sole voting and dispositive power over American Nutra Tech, LLC
More from LifeMD, Inc.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 6
Annual Report
2026
Apr 30
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 23
Regulatory Filings
2026
Jan 6
Director's Dealing
2025
Dec 11
Regulatory Filings
2025
Nov 24
Interim / Quarterly Report
2025
Nov 17
Regulatory Filings
2025
Nov 17